A phase I-II clinical trial to assess the effect of HC-SVT-1001 in the surgical treatment of atrophic pseudarthrosis of long bones

Trial Profile

A phase I-II clinical trial to assess the effect of HC-SVT-1001 in the surgical treatment of atrophic pseudarthrosis of long bones

Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 09 Oct 2017

At a glance

  • Drugs HC SVT-1001 (Primary)
  • Indications Pseudoarthrosis
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors SALVAT
  • Most Recent Events

    • 03 Oct 2017 Planned End Date changed from 1 Dec 2018 to 1 Dec 2019.
    • 03 Oct 2017 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2018.
    • 31 Mar 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top